1. Why could the Anthropic IPO valuation fall to $1 trillion?
Investors preparing to buy into the Anthropic IPO say the $1.5 trillion valuation the market had expected now looks too high after Thursday's sharp sell-off in AI-related stocks. Three investors said the price will probably have to come down, and one pointed to roughly $1 trillion, which would cut the target by a third. The comments were reported on Thursday, November 5, and the sell-off followed the U.S. midterm elections.
The reasoning is straightforward. A newly listed company is priced by weighing what buyers are willing to pay against what the seller hopes to raise, and buyers' willingness shifts quickly when comparable stocks fall. When the shares of established AI and chip companies drop by double digits in a day, investors who were prepared to pay a premium for a leading AI developer tend to ask for a discount instead.
Nothing is final. The valuation will be set closer to the offering through the usual process of gauging demand, and the remarks so far come from prospective buyers who have an interest in a lower price. Still, their willingness to say the target looks stretched is a notable change of tone for an offering that, only weeks earlier, was widely expected to be among the largest listings in history.
2. Where does the Anthropic IPO stand now?
Anthropic filed last month to list on Nasdaq under the ticker symbol ANT. According to the reporting, the company has aimed to go public in the week before Thanksgiving and to raise as much as $100 billion, a figure that would make it one of the biggest stock offerings ever. The valuation under discussion at that stage was about $1.5 trillion.
The same investors say the amount raised could shrink along with the valuation. One suggested the company might raise around $80 billion instead of the $100 billion previously targeted. Another asked whether Anthropic might delay the listing until market conditions improve, a possibility that has drawn the attention of analysts. Executives and advisers are expected to meet in the coming days to discuss how to proceed.
For readers unfamiliar with the mechanics, an initial public offering is the first sale of a company's shares to the general public. The company and its underwriting banks set a price range, present the business to large institutions in meetings, and adjust the range according to demand. A sell-off in similar stocks during this window can change that demand quickly, which is why bankers watch the broader market closely in the days before pricing.
The valuation under discussion is already below earlier expectations. In September, a leaked draft filing was reported to show the company seeking roughly $2 trillion. A move to $1.5 trillion would already have been a reduction from that level, and the latest remarks suggest the figure could slip further, to something near $1 trillion.
3. What happened to AI stocks on Thursday?
Markets fell hard on Thursday as investors reassessed the prospects of AI companies. The S&P 500 closed down 4.4% and the Nasdaq 100 dropped 6.3%, and both were their worst days since April 2025. The Philadelphia semiconductor index sank 12.3%, while Nvidia, the most prominent supplier of AI chips, lost 9.2%.
The trigger was political as much as financial. Investors weighed whether gains by Democrats in the midterm elections could lead to tighter oversight of data center construction, the building programs on which AI developers depend for computing capacity. Large chip makers and AI labs have planned very heavy spending on such facilities, so any sign that approvals or electricity supply could become harder to secure is read as a risk to their growth.
Friday morning brought a partial recovery. As of 11:21 a.m. Eastern time, the Nasdaq Composite was up 1.4% and Nvidia had gained 3.4%. A one-day bounce does not erase the previous session's losses, but it indicates that sentiment had not collapsed further, which matters to a company deciding whether to proceed with a listing in the coming weeks.
4. How does Washington politics affect the offering?
Democrats are preparing a set of bills aimed at AI and data centers. Proposals under discussion would shield consumers from electricity costs tied to data centers, require independent testing of advanced AI systems and clarify the liability of AI companies for harm their products cause. Passing any of them would face steep odds while Donald Trump is in the White House, since a president of the opposing party can veto legislation.
Even so, a party in a stronger position can do more than pass laws. Democrats also plan closer scrutiny of leading AI firms, Anthropic among them, which can mean hearings, information requests and public pressure. For a company preparing to sell shares to the public, regulatory attention is a risk factor that buyers have to price in.
Two political figures have gone further on data centers specifically. Senator Bernie Sanders, an independent from Vermont, called for a national data center moratorium. Gina Hinojosa, the governor-elect of Texas, pledged to pause data center approvals. The Texas pledge carries weight because the state hosts more than a quarter of the data center capacity planned in the United States.
5. What are analysts and investors saying?
Outside observers see the risk of a delay as rising. Richard Windsor, a technology analyst, described a postponement as an escalating risk. Nalin Patel, an analyst at PitchBook, said that delaying the listing would protect the company against near-term valuation risk and would become more likely if the market correction lasts longer.
Not everyone expects a cut. Some investors want to see Anthropic's October results before assuming that a lower valuation is needed. The company's annualized revenue run rate, which projects current monthly revenue across a full year, topped $80 billion at the end of October. It held $146.6 billion in cash as of September 30. Those figures describe a business growing quickly and sitting on substantial resources, which is the case supporters of a high valuation tend to make.
A lower valuation would not by itself signal weakness in the business. Valuation measures what the market will pay for expected future earnings, and those expectations swing with interest rates, regulation and sentiment toward an entire sector. A company can post faster growth and still see its stock price target fall if the sector it belongs to is repriced. That distinction is why some investors are waiting for the October numbers instead of reacting to a single day of trading.
The tension is therefore between the company's fundamentals and the market's mood. Strong revenue growth supports a high price, but a sudden loss of appetite for AI shares can lower what buyers will pay regardless of how well the company performs. How the offering is eventually priced will show which factor investors weighted more heavily.
6. What do prediction markets say about the timing?
Traders on prediction platforms have become more cautious. On Polymarket, the odds of an Anthropic listing by November 20 stood at 43% on Friday, while the odds of a listing by the end of the year were 71%. A December debut is now seen as more likely than a November one.
On Kalshi, where traders bet on when Anthropic will officially confirm its IPO, the probability of confirmation before December 1 fell 15 points to 59%, and the odds of confirmation before January 1 slipped to 68%. A separate prediction market showed a 71% probability of an Anthropic IPO before 2027.
Prediction market odds are not forecasts from the company or its bankers; they reflect what traders collectively expect and move with news. Still, the drop in short-term odds is consistent with the investor comments about a possible delay, and the steadiness of the year-end figure suggests traders expect the listing to happen eventually even if it moves back by a few weeks.
7. What happens next?
The next step is the meeting that executives and advisers are expected to hold in the coming days. Its outcome will indicate whether the company keeps the pre-Thanksgiving timeline, trims the amount it seeks to raise, or pushes the listing into December or later. Any change would likely be communicated to prospective investors first.
Companies in this position generally have three options: proceed at a reduced price, shrink the size of the offering, or wait. Proceeding at a lower price secures the capital and the public listing sooner but gives up value for existing shareholders. Waiting preserves the original target but risks a longer period of uncertainty and a market that may not recover. The investors quoted appear to be pointing toward the first two, and analysts have raised the third.
Several other developments could matter. The company's October results, which some investors want to see before drawing conclusions, could strengthen the case for a high price if they match the revenue run rate already reported. Stock market moves in the days ahead will show whether Thursday's rout was a one-off or the start of a longer correction, and congressional Democrats' plans for AI oversight will take shape over a longer period.
For readers following the offering, the key figures to keep in mind are the original $1.5 trillion target, the roughly $1 trillion level suggested by one investor, the $100 billion the company hoped to raise and the $80 billion alternative floated by another. Until the company confirms its plans, those numbers remain expectations rather than decisions.